25 related articles for article (PubMed ID: 19360342)
21. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Kitamura K; Ikai I; Uemoto S
Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342
[TBL] [Abstract][Full Text] [Related]
22. Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lee M; Ko H; Yun M
Yonsei Med J; 2018 Dec; 59(10):1143-1149. PubMed ID: 30450847
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.
Brito AF; Mendes M; Abrantes AM; Tralhão JG; Botelho MF
Mol Diagn Ther; 2014 Oct; 18(5):495-504. PubMed ID: 24852041
[TBL] [Abstract][Full Text] [Related]
24. Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.
Yoneda N; Matsui O; Kobayashi S; Kitao A; Kozaka K; Inoue D; Yoshida K; Minami T; Koda W; Gabata T
Jpn J Radiol; 2019 Mar; 37(3):191-208. PubMed ID: 30712167
[TBL] [Abstract][Full Text] [Related]
25. FDG accumulation and tumor biology.
Pauwels EK; Ribeiro MJ; Stoot JH; McCready VR; Bourguignon M; Mazière B
Nucl Med Biol; 1998 May; 25(4):317-22. PubMed ID: 9639291
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
